Tramadol use in pediatric sickle cell disease patients with vaso-occlusive crisis

被引:0
作者
Mary P Borgerding [1 ]
Randall K Absher [1 ]
Tsz-Yin So [2 ]
机构
[1] Department of Pharmacy, Wesley Long Hospital, Greensboro, NC 27401, United States
[2] Department of Pharmacy, Moses H Cone Memorial Hospital, Greensboro, NC 27401, United States
关键词
Pediatrics; Sickle cell; Tramadol; Morphine; Vaso-occlusive crisis;
D O I
暂无
中图分类号
R725.5 [小儿血液及淋巴系疾病];
学科分类号
100202 ;
摘要
AIM: To evaluate whether the addition of scheduled oral tramadol to intravenous morphine and intravenous ketorolac reduces morphine requirements.METHODS: This single-centered, Institutional Review Board-approved, retrospective study at Moses Cone Memorial Hospital included pediatric patients who were ≥ 2 years old with vaso-occlusive crisis(VOC) caused by sickle cell disease(SCD), were on morphine patientcontrolled analgesia(PCA), and had scheduled oral tramadol added to their standard pain regimen. The study population was admitted between March 2008 and March 2011. The data was collected from electronic records and included age, weight, morphine use, tramadol use, hemoglobin, pain scores, number of days on PCA, length of hospital stay, respiratory rate, and polyethylene glycol use. Thirty patients were analyzed as independent admissions and seven patients as paired admissions. RESULTS: Eighteen pediatric SCD patients with VOC received morphine PCA and intravenous ketorolac and twelve patients received morphine PCA and intravenous ketorolac and scheduled oral tramadol. Baseline characteristics were similar between both groups with the exception of the average weight, which was greater in the tramadol group than in the morphine group. The average morphine requirements in patients with and without the use of tramadol were similar, both for the independent admissions [0.58 mg/kg per day vs 0.65 mg/kg per day(P = 0.31)] and the paired admissions [0.71 mg/kg per day vs 0.77 mg/kg per day(P = 0.5)]. The daily polyethylene glycol requirement was less in the tramadol group for both the independent [0.5 g/kg per day vs 0.6 g/kg per day(P = 0.64)] and paired admissions analyses [and 0.41 g/kg per day vs 0.55 g/kg per day(P = 0.67)].CONCLUSION: The addition of scheduled tramadol in patients receiving concomitant morphine and ketorolac demonstrates a trend toward decreased morphine and polyethylene glycol use.
引用
收藏
页码:65 / 69
页数:5
相关论文
共 9 条
[1]  
Pain in sickle cell disease. Rates and risk factors. Platt O S,Thorington B D,Brambilla D J,Milner P F,Rosse W F,Vichinsky E,Kinney T R. The New England Quarterly . 1991
[2]  
Managing sickle cell disease. Susan Claster,Elliott P Vichinsky. British Medical Journal . 2003
[3]  
Lexicomp 2011:Tramadol. http://www.uptodate.com.libproxy.lib.unc.edu/contents/tramadol-pediatric-druginformation?detected Language=en&source=search_result&search=tramadol&selected Title=2%7E86&provider=no Pro vider .
[4]  
A pilot study on the efficacy of ketorolac plus tramadol infusion combined with erythrocytapheresis in the management of acute severe vaso-occlusive crises and sickle cell pain. de Franceschi Lucia,Finco Gabriele,Vassanelli Aurora,Zaia Barbara,Ischia Stefano,Corrocher Roberto. Haematologica . 2004
[5]  
Nature and treatment of the acute painful episodes in sickle cell disease. Benjamin L. Disorders of Hemoglobin:Genetics,Pathophysiology and Clinical Management . 2001
[6]  
Tramadol: A Review of its Use in Perioperative Pain. L.J. Scott,C.M. Perry. Drugs . 2000
[7]  
Approach to the vaso-occlusive crisis in adults with sickle cell disease. Yale S H,Nagib N,Guthrie T. American Family Physician . 2000
[8]   Guidelines for the management of the acute painful crisis in sickle cell disease [J].
Rees, DC ;
Olujohungbe, AD ;
Parker, NE ;
Stephens, AD ;
Telfer, P ;
Wright, J .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (05) :744-752
[9]   THE VALUE OF MULTIMODAL OR BALANCED ANALGESIA IN POSTOPERATIVE PAIN TREATMENT [J].
KEHLET, H ;
DAHL, JB .
ANESTHESIA AND ANALGESIA, 1993, 77 (05) :1048-1056